CA2098029C - Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees - Google Patents
Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees Download PDFInfo
- Publication number
- CA2098029C CA2098029C CA 2098029 CA2098029A CA2098029C CA 2098029 C CA2098029 C CA 2098029C CA 2098029 CA2098029 CA 2098029 CA 2098029 A CA2098029 A CA 2098029A CA 2098029 C CA2098029 C CA 2098029C
- Authority
- CA
- Canada
- Prior art keywords
- amino acid
- hiv
- acid sequence
- particle
- retrovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2098029 CA2098029C (fr) | 1993-06-09 | 1993-06-09 | Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2098029 CA2098029C (fr) | 1993-06-09 | 1993-06-09 | Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2098029A1 CA2098029A1 (fr) | 1994-12-10 |
CA2098029C true CA2098029C (fr) | 2000-10-03 |
Family
ID=4151769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2098029 Expired - Lifetime CA2098029C (fr) | 1993-06-09 | 1993-06-09 | Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2098029C (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996030523A2 (fr) * | 1995-03-31 | 1996-10-03 | Hans Wolf | Systeme de presentation d'antigenes fonde sur des particules similaires a des retrovirus |
-
1993
- 1993-06-09 CA CA 2098029 patent/CA2098029C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2098029A1 (fr) | 1994-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7008784B1 (en) | Non-infectious, non-replicating, immunogenic human immunodeficiency virus-like particles | |
Griffiths et al. | Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag: V3 fusion | |
US5866137A (en) | Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins | |
US7229625B2 (en) | Retrovirus-like particles made non-infectious by a plurality of mutations | |
JP6165612B2 (ja) | コンセンサス/先祖免疫原 | |
US5866320A (en) | Nucleic acids encoding for non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region | |
Girard et al. | Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1 | |
Cho et al. | Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous simian/human immunodeficiency virus infection in pigtailed macaques | |
CA2331599C (fr) | Vaccin de vih a deficience de replication | |
Rovinski et al. | Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine | |
Buonaguro et al. | High efficient production of Pr55gag Virus-like Particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A | |
US6544752B1 (en) | Anigenically-marked non-infectious retrovirus-like particles | |
Berzofsky | Development of artificial vaccines against HIV using defined epitopes | |
Kang et al. | Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles | |
Chakrabarti et al. | Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate | |
EP1038001B1 (fr) | Expression constitutive de particules non infectieuses du type hiv | |
CA2098029C (fr) | Particules de type retrovirus contenant des glycoproteines d'enveloppe modifiees | |
McBride et al. | Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination | |
Cranage et al. | The simian immunodeficiency virus transmembrane protein is poorly immunogenic in inactivated virus vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |